DIAMEDICA THERAPEUTICS INC (DMAC) Stock Analyst Earnings Estimates
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | -100.00% | 11.359M | 41.241M 263.07% | 79.331M 92.36% | 119.34M 50.43% | 148.63M 24.54% | 172.9M 16.33% | ||||||||||
| EBITDA YoY % growth | -2.48M -71.03% | -4.52M -82.26% | -6.74M -49.12% | -11.233M -71.66% | -11.016M -9.59% | N/A -7.49% | N/A -2.49% | -21.216M -52.02% | -26.622M -25.36% | -38.658M -45.21% | -39.066M -1.06% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.48M -71.03% | -4.52M -82.26% | -6.76M -49.56% | -12.09M -71.45% | -12.107M -9.58% | -15.531M -7.48% | -14.069M -2.56% | -21.46M -51.91% | -26.539M -24.79% | -36.413M -37.21% | -41.699M -14.51% | -44.053M -5.65% | -27.145M 38.38% | -3.37M 87.58% | 23.022M 783.13% | 44.713M 94.22% | 64.81M 44.95% | |
| Operating Margin | N/A | N/A | -1,352.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -387.82% | -65.82% | -4.25% | 19.29% | 30.08% | 37.48% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.95 -9.07% | -0.74 12.36% | -0.74 17.95% | -0.53 18.75% | -0.62 -19.23% | -0.60 2.52% | -0.81 -33.33% | -0.86 -6.96% | -0.94 -8.88% | -0.55 41.30% | -0.02 96.30% | 0.44 2,250.00% | 0.81 83.72% | 1.14 41.77% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -25.68% | -0.20 -45.71% | -0.21 -64.77% | -0.24 -63.20% | -0.23 -33.33% | -0.19 5.00% | -0.19 9.52% | -0.19 20.83% | -0.19 17.39% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | -8.058M -38.50% | -8.16M -42.33% | -9.18M -63.35% | -10.2M -48.80% | -11.22M -39.24% | -9.792M -20.00% | -9.792M -6.67% | -9.792M 4.00% | -9.792M 12.73% |
| EBIT Q2Q % growth | -7.892M -34.95% | -8.67M -51.02% | -9.18M -62.82% | -10.455M -51.90% | -10.965M -38.94% | -9.792M -12.94% | -9.792M -6.67% | -9.792M 6.34% | -9.792M 10.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 -25.00% | -0.16 | 0.01 | 5.12% |
| Q2 2024 Q2Q % growth | -0.13 18.75% | -0.16 | 0.03 | 18.65% |
| Q1 2024 Q2Q % growth | -0.14 30.00% | -0.16 | 0.02 | 12.39% |
| Q4 2023 Q2Q % growth | -0.14 | -0.14 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.12 | -0.13 | 0.01 | 7.12% |
| Q2 2023 Q2Q % growth | -0.16 -23.08% | -0.18 | 0.02 | 11.21% |
| Q1 2023 Q2Q % growth | -0.20 -53.85% | -0.16 | -0.04 | -22.55% |
| Q4 2022 Q2Q % growth | -0.14 -40.00% | -0.14 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.12 33.33% | -0.15 | 0.03 | 20.24% |
| Q2 2022 Q2Q % growth | -0.13 23.53% | -0.18 | 0.05 | 29.19% |
| Q1 2022 Q2Q % growth | -0.13 31.58% | -0.22 | 0.09 | 40.26% |
| Q4 2021 Q2Q % growth | -0.10 56.52% | -0.18 | 0.08 | 44.30% |
| Q3 2021 Q2Q % growth | -0.18 5.26% | -0.23 | 0.05 | 22.60% |
| Q2 2021 Q2Q % growth | -0.17 | -0.22 | 0.05 | 21.26% |
| Q1 2021 Q2Q % growth | -0.19 | -0.22 | 0.03 | 12.68% |
| Q4 2020 Q2Q % growth | -0.23 -9.52% | -0.17 | -0.06 | -34.22% |
| Q3 2020 Q2Q % growth | -0.19 5.00% | -0.15 | -0.04 | -27.00% |
| Q2 2020 Q2Q % growth | -0.17 19.05% | -0.16 | -0.01 | -8.70% |
| Q1 2020 Q2Q % growth | -0.19 29.63% | -0.29 | 0.10 | 34.26% |
| Q4 2019 Q2Q % growth | -0.21 | -0.25 | 0.04 | 17.21% |
| Q3 2019 Q2Q % growth | -0.20 | -0.21 | 0.01 | 6.63% |
| Q2 2019 Q2Q % growth | -0.21 | -0.26 | 0.05 | 19.79% |
| Q1 2019 Q2Q % growth | -0.27 | -0.20 | -0.07 | -32.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 12.29% | 0% | 1.25% |
| Revenue | N/A | N/A | N/A | N/A |